Modern Manufacturing Initiative – Manufacturing Translation Stream – Medical Products Priority Round 1

Overview

The Manufacturing Translation Stream will support projects that aid the translation of high quality research and ideas into commercial outcomes and support businesses to scale-up and become more competitive and resilient. It will support businesses to adopt new technologies and improve their manufacturing processes to boost productivity and competitiveness. Quality medical products are at the centre of a healthy society. They can also be the centrepiece of a dynamic economy based on translating smart ideas into globally competitive manufactured products. Medical products make a significant contribution to Australia’s economic prosperity. The sector is responsible for some of Australia’s most innovative commercial successes. Australian medical products making a global impact include the cochlear implant, green whistle and cervical cancer vaccine. For the Modern Manufacturing Initiative’s Translation and Integration Stream grant opportunities, an initial combined total of approximately $140 million is available from 2020-21 to 2023-24 across all the National Manufacturing Priorities.